
INHERITANCE OF A CHROMOSOME 3 AND 21
TRANSLOCATION IN THE FETUSES, WITH ONE ALSO
HAVING TRISOMY 21, IN THREE PREGNANCIES
IN ONE FAMILY Pazarbasi A1,*, Demirhan O1, Alptekin D1, Ozgunen FT2, Ozpak L1,
Yilmaz MB1, Nazlican E3, Tanriverdi N1, Luleyap U1, Gümürdülü D4 *Corresponding Author: Associate Professor Ayfer Pazarbasi (Ph.D.), Çukurova University, Faculty of Medicine,
Department of Medical Biology and Genetics, 01330 Adana, Turkey; Tel.: +90-322-338-6060/3498; Fax:
+90-322-338-6572; E-mail: payfer@cu.edu.tr page: 91
|
DISCUSSION
Autosomal reciprocal translocations have been
proposed as the most common chromosomal changes
in couples who have recurrent pregnancy loss
(RPL). In parallel, reciprocal translocations were the
most common abnormalities (2.9%) in our series as
reported in the literature, and all the chromosomes
that are involved in these reciprocal translocations
were found in autosomes [10]. Although reciprocal
translocations are balanced rearrangements, they
are important for the offspring of carriers who have
increased risk of a chromosomal imbalance during
gameto-genesis due to unequal meiotic segregation.
Especially when one of the parents is a carrier of a
balanced reciprocal translocation, pregnancy may result
in one of the three different types of offspring:
a child with a normal karyotype, a child with a balanced
reciprocal translocation, or a conceptus with an
unbalanced karyotype that may lead to a spontaneous
miscarriage or a live-born child with malformations
and mental retardation. Cytogenetic findings do not
only lead to RPL but also increase the frequency of
bearing a malformed child, therefore, genetic counseling
for subsequent pregnancies of couples who
have balanced translocation is important [1,3].
It is generally accepted that balanced rearrangements
lead to increased non disjunction of other
chromosomes during meiosis. Carriers of balanced
translocations may be apparent because of recurrent
miscarriages with or without healthy and/or affected
children [5].
Prenatal diagnosis is essential if there are recurrent
miscarriages for couples with a known chromosome
rearrangement and if there is advanced maternal
age. Maternal age is the only well-established
risk factor for Down Syndrome, and the associated
risk increases exponentially at age 35 years and over
[7,8,16]. As a result, amniocentesis is regularly recommended
for women at age 35 and over. It is also
recommended that case reports of clinically normal
subjects with balanced karyotypes should be published
so that an informed decision can be made prenatally
when a similar rearrangement is identified.
In the rare group of parents carrying a balanced
chromosome rearrangement affecting whole or partial
21q, the risk of having a child with a complete
or partial trisomy 21 is relatively high, with about
20.0% in females and 10.0% in males. If the translocation
chromosomes and their normal homologous
show pairing difficulties in meiosis I, the additional
risk of a 3:1 segregation has to be taken into account,
leading to a recurrence risk of up to 30.0% [6].
We concluded that carriers of reciprocal translocations
including chromosome 21 are at increased
risk of having offspring with trisomy 21. Thus, the
t(3;21) could promote formation of trisomy 21 in the
offspring. Recent studies quite clearly indicate that
interchromosomal effects (ICEs) do exist [9,17-19].
It has been hypothesized that a familial translocation
frequently induces errors of pairing of het-erologous
chromosomes in the prophase of meiosis I leading
to an aneuploid gamete (ICE). Recent investigations
could not prove this hypothesis. Kovaleva [20]
found that carriers of balanced reciprocal translocations
or inversions but not a Robertsonian translocation,
are at increased risk of bearing a trisomy 21
offspring. According to this researcher, these data
do not support the existence if ICE in its common
sense, i.e., as an effect of rearrangement on another
chromosomes’ segregation at the carrier’s meiosis.
Nowadays, it is assumed that the reduced fertility of
the translocation carriers is the reason for pregnancies
at increased maternal age that leads to an elevated
risk for pregnancies with trisomy 21 [6,15,16].
Translocation of chromosome 21 (4.0% of Down
Syndrome) recurrence risk varies between 10.0-
25.0%, if one parent is a carrier of a translocation
comprising chromosome 21 [12]. The risk of unbalanced
translocation in the offspring will depend
on both the type of translocation in the parents, and
which parent is affected and whether the translocation
is between homologous or non homologous chromosomes. If the parents are carriers of balanced
translocation, risk for unbalanced translocation in
the fetus is high and all subsequent pregnancies require
prenatal sampling.
Once an unbalanced translocation in the fetus/
child has been identified, parental karyotype is essential.
More than 50.0% of the translocations in a
fetus are de novo. So if parents have a normal karyotype,
no matter what type of translocation in the fetus,
recurrence risk is minimal <1.0% [12]. We may
then expect carriers of balanced parental structural
rearrangements to be at a greater risk of having an
offspring with a distinct aneuploidy.
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|